Sinha P, Fauvel N J, Singh S, Soni N
Magill Department of Anaesthesia, Intensive Care Medicine and Pain Management, Chelsea and Westminster Hospital, 369 Fulham Road, London SW10 9NH, UK.
Br J Anaesth. 2009 May;102(5):692-7. doi: 10.1093/bja/aep054. Epub 2009 Apr 3.
Measures of oxygenation are traditionally used to monitor the progress of patients on positive pressure ventilation. Although CO2 elimination depends on fewer variables, measures of CO2 elimination are comparatively overlooked except when monitoring patients who are difficult to ventilate. CO2 elimination is dependent upon CO2 production and alveolar ventilation, which together determine Pa(CO2). Alveolar ventilation is the efficient portion of minute ventilation ('E'). In the clinical setting, problems with CO2 elimination are observed as increasing Pa(CO2), increasing minute ventilation, or both. In conventional tests of respiratory function, actual measurements are frequently compared with predicted measurements. However, this approach has rarely been applied to the measurement of ventilatory efficiency.
We have developed a ratio, called the ventilatory ratio (VR), which compares actual measurements and predicted values of minute ventilation and Pa(CO2). VR = (V(E measured) x Pa(CO2 measured))/(V(E predicted) x Pa(CO2 predicted)). V(E predicted) is taken to be 100 (ml kg(-1) min(-1)) based on predicted body weight, and Pa(CO2 predicted)) is taken to be 5 kPa.
Inspection shows VR to be a unitless ratio that can be easily calculated at the bedside. VR is governed by carbon dioxide production and ventilatory efficiency in a logically intuitive way. We suggest that VR provides a simple guide to changes in ventilatory efficiency. A value close to 1 is predicted for normal individuals and an increasing value would correspond with worsening ventilation, increased CO2 production, or both.
VR is a new tool providing additional information for clinicians managing ventilated patients.
传统上,氧合指标用于监测接受正压通气患者的病情进展。尽管二氧化碳清除取决于较少的变量,但除了监测通气困难的患者外,二氧化碳清除指标相对被忽视。二氧化碳清除取决于二氧化碳产生量和肺泡通气量,二者共同决定动脉血二氧化碳分压(Pa(CO2))。肺泡通气是分钟通气量(“E”)中的有效部分。在临床环境中,二氧化碳清除问题表现为动脉血二氧化碳分压升高、分钟通气量增加或两者兼有。在传统的呼吸功能测试中,实际测量值经常与预测值进行比较。然而,这种方法很少应用于通气效率的测量。
我们开发了一种称为通气比率(VR)的比值,它比较分钟通气量和动脉血二氧化碳分压的实际测量值与预测值。VR = (实测分钟通气量(V(E measured))×实测动脉血二氧化碳分压(Pa(CO2 measured)))/(预测分钟通气量(V(E predicted))×预测动脉血二氧化碳分压(Pa(CO2 predicted)))。基于预测体重,预测分钟通气量(V(E predicted))取为100(ml·kg⁻¹·min⁻¹),预测动脉血二氧化碳分压(Pa(CO2 predicted))取为5 kPa。
观察发现VR是一个无量纲的比值,可在床边轻松计算。VR以逻辑直观的方式受二氧化碳产生量和通气效率的影响。我们认为VR为通气效率的变化提供了一个简单的指标。正常个体的VR值预计接近1,VR值增加则对应通气恶化、二氧化碳产生增加或两者兼有。
VR是一种新工具,可为管理通气患者的临床医生提供额外信息。